LC/MS, MALDI, Ion Mobility
IndustriesMetabolomics
ManufacturerBruker
Significance of the topic
Spot-based MALDI mass spectrometry coupled with trapped ion mobility separation (TIMS) offers a fast, low-preparation route to metabolic fingerprinting of microbial cultures. This approach addresses the growing need for high-throughput, reproducible metabolomics workflows that can screen large sample cohorts (drug screens, phenotype profiling, antibiotic response studies) with short per-sample acquisition times and straightforward automation. Integrating TIMS improves spectral clarity and peak capacity versus conventional MALDI, enabling confident detection of small-molecule changes induced by perturbations such as antibiotics.
Objectives and overview of the study
- Develop and demonstrate a streamlined MALDI-TIMS spot workflow for high-throughput bacterial metabolomics on the timsTOF fleX platform.
- Showcase software-supported feature extraction and background removal using MetaboScape 2026 to enhance specificity of detected features.
- Apply the workflow to profile metabolic responses of Escherichia coli exposed to three antibiotics (chloramphenicol, penicillin G, trimethoprim) across concentration gradients and evaluate reproducibility and specificity.
Methods and experimental workflow
- Biological model: E. coli cultures grown in Mueller-Hinton medium; four biological replicates per condition; treatments included chloramphenicol (CLO), penicillin G (PENG), and trimethoprim (TMP) at multiple concentrations referenced to MIC.
- Sample preparation: Cultures were extracted in 96-well format and diluted 1:10 prior to MALDI spotting. Dried-droplet spotting onto an AnchorChip MALDI target (800 μm) was performed using α-cyano-4-hydroxycinnamic acid (HCCA) matrix prepared in 85% acetonitrile, 0.1% TFA with 1 mM ammonium phosphate to promote ionization and crystal homogeneity.
- MALDI-TIMS-MS acquisition: Measurements were acquired in positive Full-MS mode on a timsTOF fleX with TIMS-enabled ion mobility separation. Automated laser acquisition ran at 10 kHz, and the workflow achieved acquisition times under 10 seconds per spot, permitting rapid profiling of 96 samples.
- Data processing: Raw spectra were processed in MetaboScape 2026 using the dedicated MALDI spot workflow. Blank cultivation medium spectra served as background references; features present in the medium were removed to reduce false positives. Low-intensity features (intensity ≤10) were excluded from statistical analyses. Feature extraction, mobilogram alignment and statistical visualization (PCA, series plots) were handled within MetaboScape.
Instrumentation used
- timsTOF fleX mass spectrometer (Bruker) with Trapped Ion Mobility Spectrometry (TIMS)
- AnchorChip MALDI target plate (800 μm spots)
- Laser source capable of 10 kHz acquisition (integrated in timsTOF fleX)
- MALDI matrix: α-cyano-4-hydroxycinnamic acid (HCCA) in 85% ACN, 0.1% TFA, 1 mM ammonium phosphate
- Data analysis software: MetaboScape 2026 with MALDI spot workflow
Main results and discussion
- Throughput and reproducibility: The workflow yielded reproducible mobilogram and spectral patterns across biological replicates, demonstrating high run-to-run consistency. Reported acquisition times were <10 seconds per spot, enabling high-throughput analysis of 96 samples in short total time.
- Improved spectral quality via TIMS: Incorporation of TIMS separation increased peak capacity and improved signal discrimination in complex spot spectra, aiding feature detection and downstream statistical confidence.
- Background removal effectiveness: Using blank cultivation medium spectra as an automated background reference in MetaboScape reduced matrix- and medium-derived features, increasing specificity for cellular metabolic signals and facilitating detection of treatment-related changes.
- Antibiotic-specific metabolic responses: Multivariate analysis (PCA) separated samples treated with chloramphenicol and penicillin G into distinct clusters versus controls, indicating pronounced and treatment-specific metabolic perturbations. Trimethoprim-treated samples clustered near controls, consistent with a weaker metabolic impact in this dataset—reflecting known resistance profiles of the tested E. coli strain.
- Concentration dependence: Series plots of selected features across antibiotic concentration gradients confirmed dose-dependent trends for treatment-specific biomarkers, supporting the method's quantitative sensitivity for comparative profiling.
Benefits and practical applications
- High-throughput screening: Sub-10-second per-spot acquisition makes the workflow suitable for screening large panels of conditions (antibiotic libraries, phenotypic screens, time-course experiments).
- Minimal sample preparation: Dried-droplet spotting with standard HCCA matrix and simple dilution keeps sample handling straightforward and automatable.
- Enhanced feature confidence: TIMS separation and software-driven background subtraction reduce ambiguity from coeluting species and medium-derived signals, facilitating more reliable biomarker discovery.
- Integration with downstream analysis: Detected statistically significant features can guide targeted MS/MS or orthogonal LC-MS workflows for structural elucidation and validation.
Future trends and applications
- Deeper annotation pipelines: Coupling MALDI-TIMS spot profiling with rapid on-spot or follow-up MS/MS acquisition and databases will accelerate structural identification of discriminatory metabolites.
- Automation and scale-up: Higher-density MALDI targets and robotic spotting could further increase throughput for large-scale screening campaigns and clinical research cohorts.
- Integration into multi-omics: Combining MALDI-TIMS metabolite fingerprints with genomics, proteomics or phenotypic readouts will strengthen interpretation of antibiotic mechanisms and resistance phenotypes.
- Quantitative advances: Standardization strategies (internal standards, calibration protocols) could improve the quantitative comparability of spot-based metabolomics across labs and instruments.
Conclusion
The study demonstrates a practical, rapid MALDI-TIMS spot workflow for bacterial metabolomic fingerprinting that achieves high throughput, reproducibility, and specificity when coupled with MetaboScape 2026 processing. TIMS-enhanced separation and software-guided background removal enable confident detection of antibiotic-specific metabolic responses and concentration-dependent trends. The approach is well suited to large-scale screening and discovery workflows, with clear pathways to integrate structural identification and multi-omics for deeper biological insight. Note: authors disclosed employment by the instrument vendor; results are reported for research use only and not for diagnostic purposes.
Reference
- Rudt E., Asperger A., Weinkouff S., Kessler N., Mai P.Y., Thépenier C., Aros S., Gomperts Boneca I., Neuweger H., Lewis M.R. High-throughput bacterial profiling via MALDI spot analysis: Precise characterization of antibiotic-induced metabolic responses. Bruker Technical Note / Application; 2026. (Includes Technical Note 62 for additional technical details.)
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.